John is a seasoned investor, focusing on companies across frontier technology, enterprise software, robotics, healthcare, and artificial intelligence. He gravitates towards startups that are using science and technology to break down barriers to productivity growth and enable a better future for the largest number of people.
Prior to JAZZ, John was at Osage University Partners (OUP) and Lux Capital, where he focused on building and investing in companies at the intersection of science and deep technology. He brings extensive expertise in understanding nascent technologies and how they translate into product.
John’s prior investments and board roles include Algorithmia (acq. DataRobot), Body Labs (acq. AMZN), Corelight, Clarifai, Elementary ML, Embodied Robotics, Guardant Health (NYSE: GH), Kymeta, Menlo Security, SiFive, and Streetlight Data.
John holds a BS in Biology from Cornell University. John sits on the boards of several companies in the JAZZ portfolio, including Embodied, Rarebase, Oma Fertility, and Zeitworks.
Sally Jenkins, originally from Fort Worth, Texas, is an influential and widely celebrated sportswriter who has been a columnist and feature writer for The Washington Post for over twenty years. She is the author of twelve books, four of which are New York Times bestsellers. Her books include The Real All Americans, a fascinating and inspirational revival of the lost history of the Carlisle Indian School football team, led by Jim Thorpe, who were the forerunners of today’s most exciting NFL trick-play offenses, and the No.1 bestseller Sum It Up, co-authored with legendary basketball coach, Pat Summitt, winner of eight national championships. Her latest work, The Right Call: What Sports Teach Us About Work and Life, was released in June 2023. Here, Jenkins reflects on the actionable principles of excellence she has observed in interviewing the best of the best, what qualities she consistently finds in our most beloved athletes, and how we can cultivate those same qualities in our own life.